{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:52:30Z","timestamp":1792788750508,"version":"4.5.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Drug Saf. Regul."],"abstract":"<jats:p>Despite significant advances in lung cancer treatment, patients with this disease still present with multiple symptoms that are very hard to control. Corticosteroids are widely used in patients with lung cancer, but without clear evidence for their efficacy. Thus, corticosteroids have been used for the treatment of conditions arising due to the tumor itself, adverse effects of the applied specific therapy and symptom palliation. In this review we are going to summarize clinical indications for corticosteroid use in patients with lung cancer: malignant airway obstruction, superior vena cava syndrome, brain metastases, treatment-related adverse events, anorexia and cachexia, fatigue, dyspnea, nausea and vomiting, spinal cord compression, and pain.<\/jats:p>","DOI":"10.3389\/fdsfr.2025.1528468","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T05:29:11Z","timestamp":1745472551000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Corticosteroids in lung cancer"],"prefix":"10.3389","volume":"5","author":[{"given":"Vesna","family":"\u0106eriman Krsti\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milija","family":"Gaji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonida","family":"Djukanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Jovanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejca.2022.01.028","article-title":"Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: results of the nausea\/emesis registry in oncology (NERO)","volume":"166","author":"Aapro","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1200\/JCO.2018.79.0006","article-title":"Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancer","volume":"36","author":"Arbour","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","article-title":"Cancer-related fatigue--mechanisms, risk factors, and treatments","volume":"11","author":"Bower","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B5","first-page":"751","article-title":"Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study","volume":"69","author":"Bruera","year":"1985","journal-title":"Cancer Treat. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1200\/JCO.18.02085","article-title":"Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: ASCO and SNO endorsement of the congress of neurological surgeons guidelines","volume":"37","author":"Chang","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/S1470-2045(15)00199-0","article-title":"Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial","volume":"16","author":"Chow","year":"2015","journal-title":"Lancet Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.21037\/apm-23-573","article-title":"Management of malignant superior vena cava syndrome","volume":"13","author":"Chow","year":"2024","journal-title":"Ann. Palliat. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"100225","DOI":"10.1016\/j.esmoop.2021.100225","article-title":"Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines","volume":"6","author":"Crawford","year":"2021","journal-title":"ESMO Open"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1824645","DOI":"10.1080\/2162402X.2020.1824645","article-title":"Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinoma","volume":"9","author":"Drakaki","year":"2020","journal-title":"Oncoimmunology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ncl.2007.07.015","article-title":"Medical management of brain tumor patients","volume":"25","author":"Drappatz","year":"2007","journal-title":"Neurol. Clin."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00520-007-0305-0","article-title":"High-dose corticosteroids for the management of dyspnea in patients with tumor obstruction of the upper airway","volume":"15","author":"Elsayem","year":"2007","journal-title":"Support Care Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.annonc.2020.02.016","article-title":"Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment","volume":"31","author":"Fabi","year":"2020","journal-title":"Ann. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e000457","DOI":"10.1136\/esmoopen-2018-000457","article-title":"Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors","volume":"4","author":"Fuc\u00e0","year":"2019","journal-title":"ESMO Open"},{"key":"B16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/s0885-3924(02)00487-6","article-title":"A retrospective observation of corticosteroid use at the end of life in a hospice","volume":"24","author":"Gannon","year":"2002","journal-title":"J. Pain Symptom Manage"},{"key":"B17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.critrevonc.2017.10.009","article-title":"Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: a systematic review","volume":"120","author":"Garant","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40425-018-0371-5","article-title":"Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy","volume":"6","author":"Giles","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1158\/1078-0432.CCR-22-3181","article-title":"Corticosteroids and cancer immunotherapy","volume":"29","author":"Goodman","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3322\/caac.21727","article-title":"Oncologic emergencies and urgencies: a comprehensive review","volume":"72","author":"Gould Rothberg","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"B21","doi-asserted-by":"publisher","first-page":"100278","DOI":"10.1016\/j.ctarc.2020.100278","article-title":"Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends","volume":"26","author":"Gupta","year":"2021","journal-title":"Cancer Treat. Res. Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1136\/pgmj.59.697.702","article-title":"Corticosteroids in terminal cancer--a prospective analysis of current practice","volume":"59","author":"Hanks","year":"1983","journal-title":"Postgrad. Med. J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"CD012704","DOI":"10.1002\/14651858.CD012704.pub2","article-title":"Systemic corticosteroids for the management of cancer-related breathlessness (dyspnoea) in adults","volume":"2","author":"Haywood","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3238\/arztebl.2012.0161","article-title":"Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment","volume":"109","author":"Horneber","year":"2012","journal-title":"Dtsch. Arztebl Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000534350","article-title":"Effects of early short-course corticosteroids on immune-related adverse events in non-small cell lung cancer patients receiving immune checkpoint inhibitors","volume":"102","author":"Huang","year":"2024","journal-title":"Oncology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1200\/JCO.20.03465","article-title":"Management of dyspnea in advanced cancer: ASCO guideline","volume":"39","author":"Hui","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jpainsymman.2015.10.023","article-title":"Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial","volume":"52","author":"Hui","year":"2016","journal-title":"J. Pain Symptom Manage"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e001038","DOI":"10.1136\/esmoopen-2020-001038","article-title":"Electronic address: clinicalguidelines@esmo.org. Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines\u2020","volume":"5","author":"Hui","year":"2020","journal-title":"ESMO Open"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S1470-2045(22)00508-3","article-title":"Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial","volume":"23","author":"Hui","year":"2022","journal-title":"Lancet Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1210\/jcem.83.1.4490","article-title":"A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo","volume":"83","author":"Huizenga","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11060-019-03238-4","article-title":"Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?","volume":"144","author":"Jessurun","year":"2019","journal-title":"J. Neurooncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"230203","DOI":"10.1183\/20734735.0203-2023","article-title":"Palliative care in lung cancer: tumour- and treatment-related complications in lung cancer and their management","volume":"20","author":"Jovanovic","year":"2024","journal-title":"Breathe"},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-41413-8_9","article-title":"Brain edema and corticosteroid toxicity","volume-title":"Brain tumors","author":"Kaur","year":"2023"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/neuonc\/noz046","article-title":"The impact of sequencing PD-1\/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis","volume":"21","author":"Kotecha","year":"2019","journal-title":"Neuro Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.pjnns.2018.03.002","article-title":"The evaluation of the effects of steroid treatment on the tumor and peritumoral edema by DWI and MR spectroscopy in brain tumors","volume":"52","author":"Kural","year":"2018","journal-title":"Neurol. Neurochir. Pol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11916-012-0273-z","article-title":"The role of corticosteroids in the treatment of pain in cancer patients","volume":"16","author":"Leppert","year":"2012","journal-title":"Curr. Pain Headache Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1016\/j.cllc.2019.03.001","article-title":"Impact of corticosteroid administration on outcomes following stereotactic ablative radiotherapy for non-small-cell lung cancer","volume":"20","author":"Li","year":"2019","journal-title":"Clin. Lung Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1097\/CM9.0000000000002544","article-title":"Effects of glucocorticoid use on survival of advanced non-small-cell lung cancer patients treated with immune checkpoint inhibitors","volume":"136","author":"Li","year":"2023","journal-title":"Chin. Med. J. Engl."},{"key":"B40","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1089\/jpm.2011.0260","article-title":"Dyspnea in palliative care: expanding the role of corticosteroids","volume":"15","author":"Lin","year":"2012","journal-title":"J. Palliat. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/1759-7714.13830","article-title":"Symptom trajectories during chemotherapy in patients with non-small cell lung cancer (NSCLC) and the function of prolonging low dose dexamethasone in promoting enhanced recovery after chemotherapy","volume":"12","author":"Liu","year":"2021","journal-title":"Thorac. Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1515\/jtim-2016-0011","article-title":"A little help from steroids in oncology","volume":"4","author":"Lossignol","year":"2016","journal-title":"J. Transl. Int. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/02841860500401167","article-title":"The use of corticosteroids in Swedish palliative care","volume":"45","author":"Lundstr\u00f6m","year":"2006","journal-title":"Acta Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11910-017-0713-6","article-title":"Clinical relevance of steroid use in neuro-oncology","volume":"17","author":"Ly","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(12)70090-6","article-title":"Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial","volume":"13","author":"Margolin","year":"2012","journal-title":"Lancet Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jpainsymman.2016.01.015","article-title":"Predictors of responses to corticosteroids for cancer-related fatigue in advanced cancer patients: a multicenter, prospective, observational study","volume":"52","author":"Matsuo","year":"2016","journal-title":"J. Pain Symptom Manage"},{"key":"B47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00520-016-3383-z","article-title":"Predictors of responses to corticosteroids for anorexia in advanced cancer patients: a multicenter prospective observational study","volume":"25","author":"Matsuo","year":"2017","journal-title":"Support Care Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1500108","DOI":"10.1080\/2162402X.2018.1500108","article-title":"Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system","volume":"7","author":"Maxwell","year":"2018","journal-title":"Oncoimmunology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11864-023-01081-4","article-title":"Current management options for dyspnea in cancer patients","volume":"24","author":"Mori","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00520-016-3507-5","article-title":"Predictors of response to corticosteroids for dyspnea in advanced cancer patients: a preliminary multicenter prospective observational study","volume":"25","author":"Mori","year":"2017","journal-title":"Support Care Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1191\/0269216304pm852oa","article-title":"Drugs in palliative care: results from a representative survey in Germany","volume":"18","author":"Nauck","year":"2004","journal-title":"Palliat. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-019-1019-4","article-title":"Glucocorticoids promote breast cancer metastasis","volume":"567","author":"Obradovi\u0107","year":"2019","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.21873\/anticanres.12494","article-title":"Interventions to reduce neurological symptoms in patients with GBM receiving radiotherapy: from theory to clinical practice","volume":"38","author":"Palombi","year":"2018","journal-title":"Anticancer Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3390\/cancers16091696","article-title":"Updates in cancer cachexia: clinical management and pharmacologic interventions","volume":"16","author":"Pandey","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e20924","DOI":"10.7759\/cureus.20924","article-title":"Malignant superior vena cava syndrome: state of the art","volume":"14","author":"Patriarcheas","year":"2022","journal-title":"Cureus"},{"key":"B56","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jpainsymman.2012.06.019","article-title":"Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review","volume":"46","author":"Paulsen","year":"2013","journal-title":"J. Pain Symptom Manage"},{"key":"B57","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1200\/JCO.2013.54.3926","article-title":"Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial","volume":"32","author":"Paulsen","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia","volume":"11","author":"Peixoto da Silva","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B59","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/jcsm.12360","article-title":"Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism","volume":"10","author":"Pin","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"B60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.21037\/med-22-44","article-title":"Overview of malignant central airway obstruction","volume":"7","author":"Powers","year":"2023","journal-title":"Mediastinum"},{"key":"B61","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/s0936-6555(05)80717-4","article-title":"Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases","volume":"8","author":"Priestman","year":"1996","journal-title":"Clin. Oncol. R. Coll. Radiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1200\/JCO.2012.43.9455","article-title":"Steroid-sparing effect of corticorelin acetate in peritumoral cerebral edema is associated with improvement in steroid-induced myopathy","volume":"31","author":"Recht","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1200\/JCO.19.00189","article-title":"Immune checkpoint inhibitor outcomes for patients with non-small-cell lung cancer receiving baseline corticosteroids for palliative versus nonpalliative indications","volume":"37","author":"Ricciuti","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.clinthera.2017.09.011","article-title":"Long-term systemic corticosteroid exposure: a systematic literature review","volume":"39","author":"Rice","year":"2017","journal-title":"Clin. Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11060-011-0713-3","article-title":"Corticosteroid-use in primary and secondary brain tumour patients: a review","volume":"106","author":"Ryan","year":"2012","journal-title":"J. Neurooncol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"CD013782","DOI":"10.1002\/14651858.CD013782.pub2","article-title":"Corticosteroids for the management of cancer-related fatigue in adults with advanced cancer","volume":"1","author":"Sandford","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3389\/fonc.2019.00695","article-title":"Efficiency of dexamethasone for treatment of vasogenic edema in brain metastasis patients: a radiographic approach","volume":"9","author":"Schroeder","year":"2019","journal-title":"Front. Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.jtho.2018.06.004","article-title":"Early use of systemic corticosteroids in patients with advanced NSCLC treated with nivolumab","volume":"13","author":"Scott","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e42227","DOI":"10.7759\/cureus.42227","article-title":"Superior vena cava syndrome: an umbrella review","volume":"15","author":"Shah","year":"2023","journal-title":"Cureus"},{"key":"B71","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejca.2020.12.012","article-title":"Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors","volume":"145","author":"Skribek","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ejca.2020.12.011","article-title":"Survival outcomes associated with corticosteroid use before chemoimmunotherapy in patients with advanced lung cancer","volume":"145","author":"Sorial","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00520-007-0395-8","article-title":"The use and toxicity of steroids in the management of patients with brain metastases","volume":"16","author":"Sturdza","year":"2008","journal-title":"Support Care Cancer"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.jpainsymman.2019.08.022","article-title":"A nationwide survey of Japanese palliative care physicians' practice of corticosteroid treatment for dyspnea in patients with cancer","volume":"58","author":"Suzuki","year":"2019","journal-title":"J. Pain Symptom Manage"},{"key":"B75","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s00415-008-0695-z","article-title":"Rehabilitation in primary and metastatic brain tumours: impact of functional outcomes on survival","volume":"255","author":"Tang","year":"2008","journal-title":"J. Neurol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"387","DOI":"10.6004\/jnccn.2022.0020","article-title":"Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Thompson","year":"2023","journal-title":"J Natl Compr Canc Netw."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1073274820985790","DOI":"10.1177\/1073274820985790","article-title":"Effect of systemic corticosteroid therapy on the efficacy and safety of nivolumab in the treatment of non-small-cell lung cancer","volume":"28","author":"Umehara","year":"2021","journal-title":"Cancer control."},{"key":"B78","doi-asserted-by":"publisher","first-page":"CD012002","DOI":"10.1002\/14651858.CD012002.pub2","article-title":"Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery)","volume":"7","author":"Vayne-Bossert","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1212\/wnl.39.9.1255","article-title":"Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression","volume":"39","author":"Vecht","year":"1989","journal-title":"Neurology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMcp067190","article-title":"Clinical practice. Superior vena cava syndrome with malignant causes","volume":"356","author":"Wilson","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jtho.2023.04.019","article-title":"Malignant superior vena cava syndrome: a scoping review","volume":"18","author":"Wright","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.det.2018.02.010","article-title":"Pruritus associated with targeted anticancer therapies and their management","volume":"36","author":"Wu","year":"2018","journal-title":"Dermatol Clin."},{"key":"B83","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.hoc.2023.02.011","article-title":"Lung cancer supportive care and symptom management","volume":"37","author":"Yao","year":"2023","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"B84","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1200\/JCO.2012.44.4661","article-title":"Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer","volume":"31","author":"Yennurajalingam","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jpainsymman.2010.03.017","article-title":"Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic","volume":"41","author":"Yennurajalingam","year":"2011","journal-title":"J. Pain Symptom Manage"},{"key":"B86","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/jcpt.13469","article-title":"Impact of corticosteroid use on outcomes of non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"46","author":"Zhang","year":"2021","journal-title":"J. Clin. Pharm. Ther."}],"container-title":["Frontiers in Drug Safety and Regulation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdsfr.2025.1528468\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T05:29:12Z","timestamp":1745472552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdsfr.2025.1528468\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":86,"alternative-id":["10.3389\/fdsfr.2025.1528468"],"URL":"https:\/\/doi.org\/10.3389\/fdsfr.2025.1528468","relation":{},"ISSN":["2674-0869"],"issn-type":[{"value":"2674-0869","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"article-number":"1528468"}}